Arsanis is a biotechnology company dedicated to the development
of human antibody based therapeutics against severe infectious diseases.
Arsanis is developing a pipeline of monoclonal antibody programs targeting
infectious diseases where current approaches are either ineffective or non-existent.
Since its founding in 2010, Arsanis has emerged as a leader in the field
of antibody based anti-infectives.